For instance, studies by Dasgupta et al. [42] have shown that PFKFB4 can phosphorylate transcriptional coactivator SRC-3, which results in promoting glucose flux, the same contributing to enhanced proliferation of breast cancer cells. Here, PFKFB4 is linked to breast carcinoma.